Cell-type-specific activation of c-Jun N-terminal kinase by salicylates

Journal of Cellular Physiology

Volumn 179, Issue 1, 1999, Pages 109-114

  Schwenger, Paul ^a   Alpert, Deborah ^a   Skolnik, Edward Y ^a,b   Vilček, Jan ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE; SALICYLIC ACID;

AMINO TERMINAL SEQUENCE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL SPECIFICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; ONCOGENE C JUN; PRIORITY JOURNAL;

ACETAMINOPHEN; ADENOCARCINOMA; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CERCOPITHECUS AETHIOPS; COLONIC NEOPLASMS; COS CELLS; CYCLOOXYGENASE INHIBITORS; ENZYME ACTIVATION; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; HUMANS; HYPERTONIC SOLUTIONS; IBUPROFEN; INDOMETHACIN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; ORGAN SPECIFICITY; OSMOTIC PRESSURE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-JUN; RECOMBINANT FUSION PROTEINS; SALINE SOLUTION, HYPERTONIC; SIGNAL TRANSDUCTION; SODIUM SALICYLATE; SORBITOL; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032978740     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199904)179:1<109::AID-JCP13>3.0.CO;2-W     Document Type: Article

References (36)

1. Abramson SB, Weissmann G. 1989. The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum 32:1-9.
2. Baldwin AS Jr. 1996. The NF-κB and I κB proteins: new discoveries and insights. Annu Rev Immunol 14:649-683.
3. Barnes PJ, Karin M. 1997. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071.
4. Bogoyevitch MA, Ketterman AJ, Sugden PH. 1995. Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J Biol Chem 270:29710-29717.
5. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U. 1995. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
6. Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer JL, Di Marco F, French L, Tschopp J. 1998. MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 273:12203-12209.
7. Cano E, Mahadevan LC. 1995. Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20:117-122.
8. Carpentier I, Declercq W, Malinin NL, Wallach D, Fiers W, Beyaert R. 1998. TRAF2 plays a dual role in NF-κB-dependent gene activation by mediating the TNF-induced activation of p38 MAPK and IκB kinase pathways. FEBS Lett 425:195-198.
9. Cobb MH, Xu S, Cheng M, Ebert D, Robbing D, Goldsmith E, Robinson M. 1996. Structural analysis of the MAP kinase ERK2 and studies of MAP kinase regulatory pathways. Adv Pharmacol 36:49-65.
10. Fanger GR, Gerwins P, Widmann C, Jarpe MB, Johnson GL. 1997. MEKKs, GCKs, MLKs, PAKs, TAKs, and tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr Opin Gen Dev 7:67-74.
11. Gupta S, Campbell D, Dérijard B, Davis RJ. 1995. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267:389-393.
12. Han J, Lee J-D, Bibbs L, Ulevitch RJ. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808-811.
13. Hibi M, Lin A, Smeal T, Minden A, Karin M. 1993. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev 7:2135-2148.
14. Kopp E, Ghosh S. 1994. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265:956-959.
15. Kyriakis JM, Baneriee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. 1994. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156-160.
16. Lin R, Beauparlant P, Makris C, Meloche S, Hiscott J. 1996. Phosphorylation of IκBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol Cell Biol 16:1401-1409.
17. Malinin NL, Boldin MP, Kovalenko AV, Wallach D. 1997. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385:540-544.
18. Marais R, Wynne J, Treisman R. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381-393.
19. Minden A, Lin A, Smeal T, Dérijard B, Cobb M, Davis R, Karin M. 1994 c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol Cell Biol 14:6683-6688.
20. Natoli G, Costanzo A, Ianni A, Templeton DJ, Woodgett JR, Balsano C, Levrero M. 1997. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275: 200-203.
21. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78:773-785.
22. Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T. 1996. Salicylates inhibit IκB-α phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol 156:3961-3969.
23. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, Gerritsen ME. 1997. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 272:21096-21103.
24. Raingeaud J, Gupta S, Rogers JS, Dickens M, Han J, Ulevitch RJ, Davis RJ. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270: 7420-7426.
25. Roth GJ, Stanford N, Majerus PW. 1975. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci USA 72:3073-3076.
26. Schwenger P, Skolnik EY, Vilček J. 1996. Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase by sodium salicylate. J Biol Chem 271:8089-8094.
27. Schwenger P, Bellosta P, Vietor I, Basilico C, Skolnik EY, Vilček J. 1997. Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci USA 94:2869-2873.
28. Schwenger P, Alpert D, Skolnik EY, Vilček J. 1998. Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IκB alpha phosphorylation and degradation. Mol Cell Biol 18:78-84.
29. Shapiro L, Dinarello CA. 1995. Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci USA 92:12230-12234.
30. Sluss HK, Barrett T, Dérijard B, Davis RJ. 1994. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol Cell Biol 14:8376-8384.
31. Song HY, Régnier CH, Kirschning CJ, Goeddel DV, Rothe M. 1997. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc Natl Acad Sci USA 94:9792-9796.
32. Traenckner EB-M, Pahl HL, Henkel T, Schmidt KN, Wilk S, Baeuerle PA. 1995. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J 14:2876-2883.
33. Vane JR. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biology 231:232-235.
34. Vane JR, Flower RJ, Botting RM. 1990. History of aspirin and its mechanism of action. Stroke 21:12-23.
35. Vietor I, Schwenger P, Li W, Schlessinger J, Vilček J. 1993. Tumor necrosis factor-induced activation and increased tyrosine phosphorylation of mitogen-activated protein (MAP) kinase in human fibroblasts. J Biol Chem 268:18994-18999.
36. Weissmann, G. (1991) Aspirin. Sci Am 264:84-90.